Avantium’s Green Plastic Dream Needs More Cash

Avantium’s Green Plastic Dream Needs More Cash

Mark Nichols

Wed, August 19, 2026 at 5:31 PM GMT+3 5 min read

• AVTXF 0.00%

THE GIST

Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here.

Avantium still wants to make the plastic bottle of the future. The problem is that the future keeps needing more time, more commissioning work and more shareholder cash.

WHAT HAPPENED

Avantium now expects commercial deliveries from its FDCA flagship plant in Delfzijl, the Netherlands, to begin at the end of this year.

The plant is designed to produce FDCA, the key building block for PEF, Avantium's plant-based and circular polymer marketed under the Releaf brand. Its technology converts plant-based sugars into FDCA, which can then be used to make PEF for bottles, packaging, fibers and specialty applications.

The company said the oxidation unit at the Delfzijl plant has been successfully commissioned, following the start-up of utility systems and the sugar dehydration unit. Commissioning work on the purification unit is being finalized.

The delay follows a titanium welding remediation program, completed in April, which pushed back the plant start-up and shifted expected revenues. Avantium said the issue added about €7 million of extra capital expenditure and required significant additional commissioning work.

First-half revenue fell to €4.7 million from €6.7 million a year earlier, mainly because of weaker sales in its R&D Solutions business. EBITDA came in at a loss of €18.8 million, slightly wider than the €18.5 million loss a year earlier. Cash fell to €23.9 million at June 30 from €57.5 million at the end of 2025.

To plug the gap, Avantium intends to raise at least €55 million in equity capital in the second half of 2026. It is also in talks with NOM, the regional investment agency for the Northern Netherlands, over a proposed €20 million convertible loan backed by government-related funding.

The company has called an extraordinary general meeting for September 30 to seek approval to increase its authorized share capital in connection with the equity raise and the proposed convertible loan.

Avantium has secured 22 offtake agreements for material from the FDCA plant, plus 15 capacity reservations representing more than 150 kilotonnes of future FDCA and PEF from licensed production facilities.

WHY IT MATTERS

Avantium is sitting in the sweet spot of a very big industrial promise: plastic that can reduce dependence on fossil feedstocks without asking consumers to stop buying bottles, packaging or performance materials.

One stock. Nvidia-level potential. 30M+ investors trust Moby to find it first. Get the pick. Tap here.

That is why FDCA and PEF matter. If Avantium can prove the process works at commercial scale, it could turn a long-running renewable chemistry story into a real licensing platform. The company says PEF can cut greenhouse gas emissions by up to 88% in 500 mL beverage bottle applications compared with conventional PET under representative European conditions, while remaining compatible with existing recycling systems.

That's the dream. The hard part is the plant.

Commercial-scale chemistry is not a PowerPoint business. It is steel, pipes, safety standards, purification units, capex overruns and painfully slow qualification runs. Avantium has moved closer to start-up, but the delay shows how little margin for error there is when a company is trying to commercialize new materials while still burning cash.

The financial picture makes that more urgent. The cash balance dropped by more than half in six months, while the EBITDA loss remained large. The R&D Solutions division, which could have helped cushion the burn, was hit by weaker spending from chemical industry customers as Middle East uncertainty and higher oil prices made clients more cautious.

That leaves Avantium relying on the capital markets just as it is trying to prove its biggest asset. A €55 million equity raise would strengthen the balance sheet, but it also brings dilution risk. The proposed €20 million convertible loan helps, but it depends on the equity funding coming through.

This is the classic small-cap clean-tech squeeze. The technology has promise, customers are interested and regulation is moving in the right direction. But the company still has to survive the expensive stretch between "promising pilot" and "repeatable commercial production."

Avantium is trying to narrow its focus. It sold Ray Technology intellectual property to UPM, spun out its Volta Technology into Carbeau, is working on a Parana Technology spin-out and will stop further investment in Dawn Technology. That should make the company leaner and more focused on FDCA and PEF.

That focus is sensible. Investors do not need a science fair. They need a factory that works.

WHAT'S NEXT

The immediate test is whether Avantium can complete commissioning, produce its first FDCA batches, finish qualification work and begin commercial sales under existing offtake agreements by the end of 2026.

The second test is funding. Shareholders will be watching the September 30 EGM, the planned equity raise, any underwriting support and progress on the NOM convertible loan.

The bigger prize is licensing. Avantium says full plant capacity should be reached in the second half of 2028. If Delfzijl proves the technology at scale, those 15 capacity reservations and global licensing talks start to look much more valuable. If it stumbles again, the green plastic story gets harder to finance.